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Computer-aided drug design (CADD) shift toward using
quantum-mechanics (QM)-based approaches is not only
the result of the ever growing computational power but
also due to the need for more accurate and more infor-
mative approaches to describe molecular properties and
binding characteristics than the currently available ones.
QM-approaches do not suffer from the limitations
inherent to the ball-and-spring description and the fixed
atom-centered charge approximation in the classical
force fields mostly used by CADD methods.[1] We
introduce a protocol for shifting 3D-QSAR, one of the
most widely used ligand-based drug design approaches,
through using QM-based molecular interaction fields
(MIFs) which are the electron density (r), hydrogen
bond donor field (HDF), hydrogen bond acceptor field
(HAF) and molecular lipophilicity potential (MLP) to
overcome the limitations of the current force-field-based
MIFs (FF-MIFs). The average performance of the
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Figure 1 Performance of the different 3D-QSAR approaches in the external validation.
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QM-MIFs (QMFA) models for nine data sets was found
to be better than that of the conventional FF-MIFs mod-
els. In the individual data sets, the QMFA models always
perform better than, or as well as, the conventional
approaches. It is particularly encouraging that the rela-
tive performance of the QMFA models improves in the
external validation (Figure 1).
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